POCI
What one share of Precision Optics Corporation holds
Electromedical and Electrotherapeutic Apparatus
We have been a developer and manufacturer of advanced optical instruments since 1982, and we operate primarily in two key market segments: medical devices and advanced defense/aerospace products.
Precision Optics Corporation’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.70 |
|---|---|
| Profit | −$0.43 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | −$0.23 |
| Cash and investments | $0.90 |
| Debt | $0.12 |
| Book value | $1.85 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $6.77 | −$3.17 | — | −$1.25 | — | −$3.69 |
| 2012 | $5.06 | $2.33 | $0.00 | −$3.73 | — | $1.25 |
| 2013 | $2.15 | −$1.52 | $0.01 | −$1.11 | — | $1.15 |
| 2014 | $2.46 | −$0.78 | $0.00 | −$0.60 | — | $0.50 |
| 2015 | $1.87 | −$0.56 | $0.03 | −$0.40 | — | $0.31 |
| 2016 | $1.64 | −$0.45 | $0.00 | −$0.37 | — | $0.23 |
| 2017 | $1.13 | −$0.36 | $0.01 | −$0.25 | — | $0.19 |
| 2018 | $1.23 | −$0.12 | $0.00 | $0.03 | — | $0.17 |
| 2019 | $1.78 | −$0.15 | $0.04 | −$0.31 | — | $0.84 |
| 2020 | $2.29 | −$0.33 | $0.03 | −$0.16 | — | $0.63 |
| 2022 | $2.96 | −$0.18 | $0.02 | −$0.20 | — | $1.59 |
| 2023 | $3.71 | −$0.03 | $0.00 | −$0.02 | — | $1.99 |
| 2024 | $3.15 | −$0.49 | $0.04 | −$0.49 | — | $1.66 |
| 2025 | $2.81 | −$0.85 | $0.03 | −$0.53 | — | $1.59 |
| 2026 | $3.70 | −$0.43 | $0.05 | −$0.23 | — | $1.85 |